GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
6MML | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMX | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMX | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMH | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMH | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMP | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMP | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMR | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMR | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMN | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMN | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMV | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6MMV | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
6WHU | P35439 | GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 1 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHU | Q00960 | GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 1 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHV | P35439 | GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 2 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHV | Q00960 | GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 2 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHR | P35439 | GluN1b-GluN2B NMDA receptor in non-active 2 conformation at 4 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHR | Q00960 | GluN1b-GluN2B NMDA receptor in non-active 2 conformation at 4 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6CNA | P35439 | GluN1-GluN2B NMDA receptors with exon 5 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6CNA | Q00960 | GluN1-GluN2B NMDA receptors with exon 5 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHT | P35439 | GluN1b-GluN2B NMDA receptor in active conformation at 4.4 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHT | Q00960 | GluN1b-GluN2B NMDA receptor in active conformation at 4.4 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WI0 | P35439 | GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WI0 | Q00960 | GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHS | P35439 | GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6WHS | Q00960 | GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
6UTO | A0A0U4BD45 | Native E. coli Glyceraldehyde 3-phosphate dehydrogenase | Glyceraldehyde-3-phosphate dehydrogenase (E.C.1.2.1.-) |
6UTN | A0A0U4BD45 | Native E. coli Glyceraldehyde 3-phosphate dehydrogenase | Glyceraldehyde-3-phosphate dehydrogenase (E.C.1.2.1.-) |
6UBS | O93430 | Full length Glycine receptor reconstituted in lipid nanodisc in Apo/Resting conformation | Glycine receptor subunit alphaZ1 |
6UBT | O93430 | Full length Glycine receptor reconstituted in lipid nanodisc in Gly-bound desensitized conformation | Glycine receptor subunit alphaZ1 |
6UAZ | A0A179UGT5 | Crystal structure of a GH128 (subgroup III) curdlan-specific exo-beta-1,3-glucanase from Blastomyces gilchristii (BgGH128_III) in complex with glucose | Glyco_hydro_cc domain-containing protein |
3CEH | P06737 | Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688 | Glycogen phosphorylase (E.C.2.4.1.1) |
3CEM | P06737 | Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423 | Glycogen phosphorylase (E.C.2.4.1.1) |
2ATI | P06737 | Glycogen Phosphorylase Inhibitors | Glycogen phosphorylase, liver form (E.C.2.4.1.1) |
1L7X | P06737 | Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.1.1.) |
1L5Q | P06737 | Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
1L5S | P06737 | Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
1XC7 | P00489 | Binding of beta-D-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: Kinetic and crystallographic studies | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
1XL0 | P00489 | Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site. | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
1XL1 | P00489 | Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site. | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
3SYM | P00489 | Glycogen Phosphorylase b in complex with 3 -C-(hydroxymethyl)-beta-D-glucopyranonucleoside of 5-fluorouracil | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
3SYR | P00489 | Glycogen phosphorylase b in complex with beta-D-glucopyranonucleoside 5-fluorouracil | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
5LRC | P00489 | Crystal structure of Glycogen Phosphorylase in complex with KS114 | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
5OX0 | P00489 | Glycogen Phosphorylase in complex with CK898 | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
5OX3 | P00489 | Glycogen Phosphorylase in complex with SzB102v | Glycogen phosphorylase, muscle form (E.C.2.4.1.1) |
1S4N | P27809 | Crystal structure of yeast alpha1,2-mannosyltransferase Kre2p/Mnt1p | Glycolipid 2-alpha-mannosyltransferase (E.C.2.4.1.131) |
6TMR | P0C572 | Mokola virus glycoprotein, monomeric post-fusion conformation | Glycoprotein |
6VY2 | A0A0A7I3C6 | Cryo-EM structure of M1214_N1 Fab in complex with CH505 TF chimeric SOSIP.664 Env trimer | Glycoprotein 120, Glycoprotein 41, M1214 N1 Fab heavy chain, M1214 N1 Fab light chain |
6VY2 | Q2N0S5 | Cryo-EM structure of M1214_N1 Fab in complex with CH505 TF chimeric SOSIP.664 Env trimer | Glycoprotein 120, Glycoprotein 41, M1214 N1 Fab heavy chain, M1214 N1 Fab light chain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024